chr10-43112848-T-C

Variant names:

• chr10-43112848-T-C
• rs876658485
• NM_020975.6:c.1649-5T>C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2 BP4_Strong BP6

The NM_020975.6(RET):​c.1649-5T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,457,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

• Frequency:
  • Genomes: not found (cov: 33)
  • Exomes 𝑓: 0.0000027 (0 hom.)
• Consequence: RET NM_020975.6 splice_region, intron
• Scores: Splicing: ADA: 0.001818
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1 B:1
• Conservation: PhyloP100: 0.286
• Publications: 0 publications found

Genes affected

RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]

RET Gene-Disease associations (from GenCC):

• familial medullary thyroid carcinoma

  Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
• multiple endocrine neoplasia type 2A

  Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
• multiple endocrine neoplasia type 2B

  Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
• pheochromocytoma

  Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
• Hirschsprung disease, susceptibility to, 1

  Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
• Haddad syndrome

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• Hirschsprung disease

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• renal agenesis, unilateral

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• bilateral renal agenesis

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
• renal agenesis

  Inheritance: AR Classification: LIMITED Submitted by: G2P

ACMG classification

Our verdict: Likely_benign. The variant received -3 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.73).
• BP6: Variant 10-43112848-T-C is Benign according to our data. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288. Variant chr10-43112848-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 230288.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
RET	NM_020975.6	c.1649-5T>C		splice_region_variant, intron_variant	Intron 8 of 19	ENST00000355710.8	NP_066124.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
RET	ENST00000355710.8	c.1649-5T>C		splice_region_variant, intron_variant	Intron 8 of 19	5	NM_020975.6	ENSP00000347942.3

Frequencies

GnomAD3 genomes Cov.: 33

GnomAD4 exome AF: 0.00000274 AC: 4 AN: 1457846 Hom.: 0 Cov.: 31 AF XY: 0.00000276 AC XY: 2 AN XY: 725428

African (AFR) AF: 0.00 AC: 0 AN: 33424

American (AMR) AF: 0.00 AC: 0 AN: 44698

Ashkenazi Jewish (ASJ) AF: 0.0000766 AC: 2 AN: 26096

East Asian (EAS) AF: 0.00 AC: 0 AN: 39668

South Asian (SAS) AF: 0.00 AC: 0 AN: 86146

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53236

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5760

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 1108574

Other (OTH) AF: 0.0000332 AC: 2 AN: 60244

GnomAD4 genome Cov.: 33

Alfa AF: 0.00 Hom.: 0

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:1 Benign:1

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1

Aug 29, 2024

Ambry Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.1649-5T>C intronic variant results from a T to C substitution 5 nucleotides upstream from coding exon 9 in the RET gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Multiple endocrine neoplasia, type 2 Benign:1

Nov 25, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.73
CADD	Benign	12
DANN	Benign	0.78
PhyloP100		0.29

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Benign	0.0018
dbscSNV1_RF	Benign	0.18
SpliceAI score (max)		0.080		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs876658485; hg19: chr10-43608296;